Establishing Mechanisms Between Traumatic Brain Injury and Dementia Using Epidemiology, Clinical Studies, Blood-Based Biomarkers, and Neuroimaging Biomarkers
利用流行病学、临床研究、血液生物标志物和神经影像生物标志物建立创伤性脑损伤和痴呆之间的机制
基本信息
- 批准号:10610962
- 负责人:
- 金额:$ 22.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAlzheimer&aposs disease related dementiaAtherosclerosis Risk in CommunitiesBiological AssayBiological MarkersBloodBlood VesselsBlood brain barrier dysfunctionCerebrovascular CirculationCerebrovascular TraumaChronicClinicalClinical ResearchCognitiveCohort StudiesCollaborationsCommunitiesDataData CollectionDementiaDiseaseEndotheliumEnvironmentEpidemiologyFreezingFunctional disorderFundingFutureGoalsHealthImpaired cognitionIndividualInjuryInstitutionInterventionKnowledgeLinkMagnetic Resonance ImagingMeasurementMeasuresMediatingMethodsMorbidity - disease rateMulticenter StudiesNational Institute of Neurological Disorders and StrokeNerve DegenerationNeurocognitiveOutcomePathway interactionsPatient RecruitmentsPennsylvaniaPersonsPopulation Scientist Supplement (R25)PreventionProcessProspective, cohort studyRecommendationReportingResearchRoleSamplingSourceSpecimenTBI PatientsTBI treatmentTimeTrainingTraumatic Brain InjuryTraumatic brain injury related dementiaUnited StatesUniversitiesVascular DiseasesWorkacute careblood-based biomarkerblood-brain barrier functioncareercerebrovascularclinical centerclinical epidemiologyclinical implementationcohortdementia riskdesigneffective therapyepidemiology studyfollow-uphigh riskimprovedmodifiable riskmortalitymultimodalityneuroimaging markerneuroinflammationnovelpreventprogramsprospectiveprotein aggregationrecruitskillssymposiumtherapeutic targettrauma centersvalidation studiesvascular injury
项目摘要
PROJECT SUMMARY / ABSTRACT
Traumatic brain injury (TBI) is common and is associated with significant morbidity and mortality. The sequelae
from TBI can be long-lasting, and multiple studies have reported an increased rate of cognitive decline and higher
risk of dementia among persons with TBI. However, the mechanisms linking TBI to dementia remain poorly
understood, although vascular dysfunction, neuroinflammation, and aggregation of proteins have been
proposed. This gap in knowledge was recently highlighted in the 2020 Lancet Commission on Dementia, which
added TBI as one of twelve potentially modifiable risk factors for dementia, and in the 2019 NINDS Alzheimer’s
Disease-Related Dementias (ADRD) Summit, which formally recommended further study into the role of TBI in
dementia, including an emphasis on studying mechanism and developing TBI-AD/ADRD-related biomarkers. To
directly address this research need, this application builds on my prior NINDS R25 award and proposes to use
epidemiology, clinical studies, and vascular-related blood-based and neuroimaging biomarkers to investigate
vascular injury and subsequent vascular dysfunction as mechanisms linking TBI and dementia.
The central hypothesis of this proposal is that TBI is associated with cognitive decline and dementia risk in part
via vasculopathy-mediated pathways which accelerate neurodegeneration for years post-TBI. This proposal will
leverage existing data from 2 ongoing prospective cohort studies (Aims 1 and 2) and new data from a
prospectively recruited cohort (Aim 3). The aims of this study are: 1) to determine if acute vascular injury is
associated with poor short-term TBI-related cognitive outcomes in the trauma center-based Transforming
Research and Clinical Knowledge in TBI (TRACK-TBI) Study, 2) to investigate if chronic vascular dysfunction
mediates associations of TBI with poor long-term cognitive outcomes in the community-based Atherosclerosis
Risk in Communities (ARIC) Study, and 3) to evaluate if the trajectory of post-TBI vascular dysfunction is
associated with short-term cognitive outcomes in a prospectively recruited cohort nested within ongoing studies
at the University of Pennsylvania Trauma Center. The overall objective of this proposal is to use multi-modal
biomarkers of vasculopathy to investigate mechanisms linking TBI and neurocognitive outcomes and to identify
time-periods during which future interventions may be effective at preventing TBI-related dementia.
In addition to the proposed research, this project will provide me with critical gap-based training, including in the
design, conduct, and implementation of clinical-epidemiologic studies and in the use of biomarkers as a method
to investigate disease mechanisms linking TBI to outcomes in clinical-epidemiologic studies. This training will
enable me to build an independent research program focused on vascular health in TBI with the goal of
elucidating disease mechanisms and characterizing TBI outcomes using well-designed prospective clinical-
epidemiologic studies of individuals with TBI. Completion of the proposed study will be facilitated by an
institutional environment that prioritizes collaboration and provides exemplary research and career support.
项目总结/摘要
创伤性脑损伤(TBI)是常见的,并且与显著的发病率和死亡率相关。后遗症
TBI可能是持久的,多项研究报告了认知能力下降的速度增加,
TBI患者患痴呆症的风险。然而,将TBI与痴呆联系起来的机制仍然很差
理解,虽然血管功能障碍,神经炎症和蛋白质聚集已经被
提出了最近,2020年《柳叶刀》痴呆症委员会强调了这一知识差距,
在2019年的NINDS阿尔茨海默氏症中,TBI是痴呆症的12个潜在可改变的风险因素之一,
疾病相关性痴呆(ADRD)峰会,正式建议进一步研究TBI在
包括研究机制和开发TBI-AD/ADRD相关的生物标志物。到
直接解决这个研究需要,这个应用程序建立在我以前的NINDS R25奖,并建议使用
流行病学、临床研究以及血管相关的血液和神经影像学生物标志物,
血管损伤和随后的血管功能障碍作为联系TBI和痴呆的机制。
这项提议的中心假设是,TBI与认知能力下降和痴呆风险部分相关。
通过血管病变介导的途径加速TBI后数年的神经变性。这项建议会
利用来自2项正在进行的前瞻性队列研究(目的1和2)的现有数据和来自
前瞻性招募队列(目标3)。本研究的目的是:1)确定急性血管损伤是否
与创伤中心转型中短期TBI相关认知结果不良相关
TBI研究和临床知识(TRACK-TBI)研究,2)研究慢性血管功能障碍
在社区动脉粥样硬化治疗中,
社区风险(ARIC)研究,以及3)评估TBI后血管功能障碍的轨迹是否
与正在进行的研究中前瞻性招募的队列中的短期认知结果相关
在宾夕法尼亚大学创伤中心本提案的总体目标是使用多式联运
血管病变的生物标志物,以研究TBI和神经认知结果之间的联系机制,
未来干预措施可能有效预防TBI相关痴呆的时间段。
除了拟议的研究,这个项目将为我提供关键的差距为基础的培训,包括在
设计、实施和实施临床流行病学研究,并使用生物标志物作为方法
研究TBI与临床流行病学研究结果之间的疾病机制。本次培训将
使我能够建立一个专注于TBI血管健康的独立研究计划,目标是
阐明疾病机制和表征TBI结果使用精心设计的前瞻性临床-
TBI患者的流行病学研究。拟议研究的完成将由一个
优先考虑合作并提供示范性研究和职业支持的机构环境。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Associations of Prior Head Injury With Olfaction in Older Adults: Results From the Atherosclerosis Risk in Communities (ARIC) Study.
老年人先前头部受伤与嗅觉的关联:社区动脉粥样硬化风险 (ARIC) 研究的结果。
- DOI:10.1001/jamaoto.2022.1920
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Schneider,AndreaLC;Gottesman,RebeccaF;Mosley,ThomasH;Shrestha,Srishti;Rowan,NicholasR;Sharrett,ARichey;Chen,Honglei;Kamath,Vidyulata
- 通讯作者:Kamath,Vidyulata
Always Look on the Bright Side: Associations of Optimism With Functional Outcomes After Stroke.
- DOI:10.1161/jaha.122.027959
- 发表时间:2023-03-07
- 期刊:
- 影响因子:5.4
- 作者:Sloane, Kelly L.;Kasner, Scott E.;Favilla, Christopher G.;Rothstein, Aaron;Witsch, Jens;Hamilton, Roy H.;Schneider, Andrea L. C.
- 通讯作者:Schneider, Andrea L. C.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrea Lauren Christman Schneider其他文献
Andrea Lauren Christman Schneider的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrea Lauren Christman Schneider', 18)}}的其他基金
Establishing Mechanisms Between Traumatic Brain Injury and Dementia Using Epidemiology, Clinical Studies, Blood-Based Biomarkers, and Neuroimaging Biomarkers
利用流行病学、临床研究、血液生物标志物和神经影像生物标志物建立创伤性脑损伤和痴呆之间的机制
- 批准号:
10449172 - 财政年份:2022
- 资助金额:
$ 22.93万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 22.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 22.93万 - 项目类别:
Standard Grant